<DOC>
	<DOCNO>NCT01594294</DOCNO>
	<brief_summary>The purpose study ass compare effect repeat usage 2 different care system ( one hydrogen peroxide base clean disinfect system one PHMB contain multipurpose system ) ACUVUE® 2® AIR OPTIX® AQUA contact lenses worn daily wear basis 3-month period .</brief_summary>
	<brief_title>An Evaluation Marketed Contact Lens Disinfectant Systems Eyelid Tissues</brief_title>
	<detailed_description>This study divide 2 period , Screening Phase Investigational Phase . During Screening Phase , subject fit dispense either ACUVUE® 2® ( current hydrogel wearer ) AIR OPTIX® AQUA ( current silicone hydrogel wearer ) contact lens use COMPLETE® MPS Easy Rub® Formula clean disinfect lens . At completion Screening Phase , symptomatic status subject re-assessed . Those subject qualify proceeded Investigational Phase dispense new pair study contact lenses identical lens wear Screening Phase use conjunction allocate study care product , CLEAR CARE® /AOSEPT® Plus ReNu MultiPlus® .</detailed_description>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Contact Lens Solutions</mesh_term>
	<mesh_term>Hydrogen Peroxide</mesh_term>
	<criteria>Read understand Participant Information Sheet ; Read , sign , date Informed Consent ; Successfully wear frequent replacement hydrogel silicone hydrogel contact lens brand frequent replacement ( biweekly monthly ) daily wear modality ; Classified symptomatic accord protocolspecified criterion ; Agree wear study contact lenses direct duration study ; Best correct visual acuity ( BCVA ) 6/9 good eye ; Other protocoldefined inclusion criterion may apply . Any known sensitivity intolerance contact lenses contact lens care product use ; Monocular vision ( one eye functional vision one eye fit contact lens ) ; History seasonal allergy , may adverse impact contact lens wear , data information obtain study ; Systemic disease use medication might interfere contact lens wear produce dry eye side effect ; Ocular allergies ocular disease might interfere contact lens wear data information obtain study ; Active ocular infection ; Use concomitant topical ocular medication study period ; Significant ocular anomaly ; Previous ocular surgery ; History recent , significant change visual acuity ; Any medical condition might prejudicial study ; Pregnant , plan become pregnant , lactating time enrollment ; Any infectious disease ( e.g . hepatitis , tuberculosis ) , immunosuppressive disease ( e.g . HIV ) , diabetes ; Participation investigational drug device study within 30 day enter study ; Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>CLEAR CARE®</keyword>
	<keyword>AOSEPT® Plus</keyword>
	<keyword>ReNu MultiPlus®</keyword>
	<keyword>silicone hydrogel</keyword>
	<keyword>hydrogel</keyword>
	<keyword>ACUVUE® 2®</keyword>
	<keyword>AIR OPTIX® AQUA</keyword>
	<keyword>eyelid response</keyword>
	<keyword>wettability</keyword>
	<keyword>contamination</keyword>
	<keyword>contact lens</keyword>
</DOC>